Related Experiment Video
Updated: May 8, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Protein phosphatase 4 is phosphorylated and inactivated by Cdk in response to spindle toxins and interacts with
Martin Voss1, Kathryn Campbell, Nastja Saranzewa
1Medical Research Council Protein Phosphorylation and Ubiquitylation Unit; College of Life Sciences; University of Dundee; Dundee, Scotland, UK.
Abstract:
Many pharmaceuticals used to treat cancer target the cell cycle or mitotic spindle dynamics, such as the anti-tumor drug, paclitaxel, which stabilizes microtubules. Here we show that, in cells arrested in mitosis with the spindle toxins, nocodazole, or paclitaxel, the endogenous protein phosphatase 4 (Ppp4) complex Ppp4c-R2-R3A is phosphorylated on its regulatory (R) subunits, and its activity is inhibited. The phosphorylations are blocked by roscovitine, indicating that they may be mediated by Cdk1-cyclin B. Endogenous Ppp4c is enriched at the centrosomes in the absence and presence of paclitaxel, nocodazole, or roscovitine, and the activity of endogenous Ppp4c-R2-R3A is inhibited from G 1/S to the G 2/M phase of the cell cycle. Endogenous γ-tubulin and its associated protein, γ-tubulin complex protein 2, both of which are essential for nucleation of microtubules at centrosomes, interact with the Ppp4 complex. Recombinant γ-tubulin can be phosphorylated by Cdk1-cyclin B or Brsk1 and dephosphorylated by Ppp4c-R2-R3A in vitro. The data indicate that Ppp4c-R2-R3A regulates microtubule organization at centrosomes during cell division in response to stress signals such as spindle toxins, paclitaxel, and nocodazole, and that inhibition of the Ppp4 complex may be advantageous for treatment of some cancers.
Insights
Cancer drugs targeting cell cycle dynamics inhibit the protein phosphatase 4 (Ppp4) complex during mitosis. This inhibition regulates microtubule organization, suggesting Ppp4 complex inhibition may aid cancer treatment.
Area of Science:
- Cell Biology
- Molecular Oncology
- Biochemistry
Background:
- Cancer therapeutics often target cell cycle regulation and mitotic spindle dynamics.
- Paclitaxel, a chemotherapy agent, stabilizes microtubules, impacting cell division.
- The protein phosphatase 4 (Ppp4) complex plays a role in cellular processes.
Purpose of the Study:
- To investigate the regulation and activity of the Ppp4 complex (Ppp4c-R2-R3A) in cells treated with spindle-targeting drugs.
- To determine the role of Ppp4 complex in microtubule organization during mitosis.
- To explore the potential of Ppp4 complex inhibition as a cancer therapy strategy.
Main Methods:
- Cell cycle arrest using nocodazole or paclitaxel.
- Phosphorylation analysis of Ppp4 complex regulatory subunits.
- Immunofluorescence to detect Ppp4 complex localization at centrosomes.
- In vitro kinase and phosphatase assays using recombinant proteins.
Main Results:
- Ppp4 complex (Ppp4c-R2-R3A) undergoes inhibitory phosphorylation on regulatory subunits during mitosis.
- Cdk1-cyclin B is implicated as the kinase mediating these phosphorylations.
- Ppp4 complex activity is inhibited from G1/S to G2/M phase.
- Ppp4 complex interacts with gamma-tubulin and gamma-tubulin complex protein 2 at centrosomes.
- Ppp4 complex dephosphorylates gamma-tubulin in vitro.
Conclusions:
- The Ppp4 complex regulates microtubule organization at centrosomes in response to spindle toxins.
- Inhibition of the Ppp4 complex during mitotic stress is a key regulatory mechanism.
- Targeting Ppp4 complex inhibition could be a promising strategy for certain cancer treatments.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Anaphase Promoting Complex
Microtubule Instability
Positive Regulator Molecules

